We began this 3-part preclinical imaging learning mini-series with this 60-minute webinar in which we will highlight five important preclinical imaging modalities including optical imaging, high frequency ultrasound, MRI, PET/CT, and fluorescence in vivo endomicroscopy. We gave a brief technical overview of each modality and discuss how an image is acquired. We then reviewed the strengths and weaknesses of each technology and provided some insight on when to use one over the other by highlighting some example images acquired on preclinical systems offered by Scintica Instrumentation.
Different types of preclinical imaging applications
Katie Parkins, PhD
Katie Parkins holds a PhD from the University of Western Ontario in Medical Biophysics. Throughout her research training she was focused on the development and application of novel molecular imaging tools to monitor and treat disease, specifically, cancer. Additionally, Katie completed a Postdoctoral Fellowship at Johns Hopkins University where she used multimodal imaging to investigate the molecular mechanisms that may determine immunotherapy response. In her present role as Preclinical Imaging Specialist at Scintica Instrumentation, Katie supports our customers in understanding the products offered and how these instruments help to meet their research needs.
Mohammedayaz Rangrez, PhD
Dr. Mohammedayaz Rangrez is an imaging scientist with a Ph.D. in preclinical research on a bilateral ovariectomy model for osteoporosis. He has a broad background in microscopy, biochemistry, physiology, and drug discovery. He was associated with the European Molecular Biology Laboratories, Heidelberg, Germany as a Technical Officer, developing e-learning courses on super-resolution microscopy. Previously, Dr. Rangrez was working as a Product Manager for in vivo microscopy at Scintica Instrumentation, with his expertise in application development and training. At present Dr. Rangrez is working as a research associate in Sunnybrook Hospital and University Health Network, Toronto, Canada.